Αποτελέσματα Αναζήτησης
29 Ιουλ 2021 · Based on existing evidence, neurologists should recommend COVID-19 vaccination to their patients. For those patients being treated with immunotherapies, attention should be paid to timing of vaccination with respect to treatment and the potential for an attenuated immune response.
11 Δεκ 2023 · In this study, we pooled and summarized available evidence to enhance the knowledge of the course and prognosis of the neuromuscular diseases associated with COVID-19 vaccines, which can lead to a well-timed diagnosis and management of these patients.
25 Απρ 2023 · To discern the central (CNS) and peripheral nervous system (PNS) manifestations associated with COVID-19 vaccines from individual case studies and describe their clinical and imaging findings, management, and outcomes.
Articles were screened for a focus on neurological disease occurrence or worsening following SARS-CoV-2 vaccination. Neurological disease included central and peripheral nervous system complications, including but not limited to autoimmune diseases, cerebrovascular disease, and psychiatric disease.
25 Μαΐ 2023 · To monitor for vaccine-related adverse events, we prospectively identified patients hospitalized for prespecified neurologic conditions who received mRNA or adenovirus COVID-19 vaccines and assessed cases for potential risk factors and alternative etiologies of the adverse event.
27 Απρ 2023 · In the current study, neurological complications reported post-COVID-19 vaccination were systematically reviewed. The current meta-analysis aims to provide clinicians with a comprehensive understanding of this uncommon adverse event.
23 Απρ 2022 · In this position paper, the Task Force (a) summarizes the current knowledge on the prognosis of COVID-19 among patients with neurological disease, (b) discusses potential barriers to vaccination coverage, and (c) formulates strategies to overcome vaccination hesitancy.
